Acrospire Investment Management’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

Acrospire Investment Management’s Portfolio ECTE Stock Details ECTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,200	Closed	–	–	2840
2017 Q1	$0	Hold	3,200	–	–	﹤0.01%	2716
2016 Q4	$1K	Hold	3,200	–	–	﹤0.01%	2160
2016 Q3	$1K	Buy	3,200 +200	+7%	+$283	﹤0.01%	1945
2016 Q2	$4K	Buy	+3,000	New	+$4.8K	﹤0.01%	1901

Other funds holding ECTE

EWM

Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

Acrospire Investment Management's ECTE Position: Q2 2017 in Review

Acrospire Investment Management sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q2 2017, closing a stake of 3,200 shares.

Acrospire Investment Management first reported a position in ECTE in Q2 2016 and held it in 4 quarters. The position peaked at $4K in Q2 2016. 1 fund tracked by Wall St. Rank holds ECTE as of Q2 2017.

Acrospire Investment Management reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q2 2017 after selling out during the quarter.
Acrospire Investment Management sold 3,200 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q2 2017.
Acrospire Investment Management first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q2 2016 and held it in 4 quarters.
Acrospire Investment Management's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $4K in Q2 2016.
1 fund tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q2 2017.

Based on Acrospire Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.